The Triglyceride/High-Density Lipoprotein Cholesterol (TG/HDL-C) Ratio as a Risk Marker for Metabolic Syndrome and Cardiovascular Disease
Diagnostics · 01.03.2023 · 13 (5) · 929
DOI: 10.3390/diagnostics13050929 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Diagnostics, online erschienen am 01.03.2023. Verfasst von Constantine E Kosmas und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Department of Medicine, Montefiore Medical Center, Bronx, NY 10467, USA. Die Arbeit wurde bisher 329-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Atherosclerosis is an immunoinflammatory pathological procedure in which lipid plaques are formed in the vessel walls, partially or completely occluding the lumen, and is accountable for atherosclerotic cardiovascular disease (ASCVD). ACSVD consists of three components: coronary artery disease (CAD), peripheral vascular disease (PAD) and cerebrovascular disease (CCVD). A disturbed lipid metabolism and the subsequent dyslipidemia significantly contribute to the formation of plaques, with low-density lipoprotein cholesterol (LDL-C) being the main responsible factor. Nonetheless, even when LDL-C is well regulated, mainly with statin therapy, a residual risk for CVD still occurs, and it is attributable to the disturbances of other lipid components, namely triglycerides (TG) and high-density lipoprotein cholesterol (HDL-C). Increased plasma TG and decreased HDL-C levels have been associated with metabolic syndrome (MetS) and CVD, and their ratio, TG/HDL-C, has been proposed as a novel biomarker for predicting the risk of both clinical entities. Under these terms, this review will present and discuss the current scientific and clinical data linking the TG/HDL-C ratio with the presence of MetS and CVD, including CAD, PAD and CCVD, in an effort to prove the value of the TG/HDL-C ratio as a valuable predictor for each aspect of CVD.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Cardiology, Department of Medicine, Montefiore Medical Center, Bronx, NY 10467, USA.
- Cardiology Clinic, Cardiology Unlimited, PC, New York, NY 10033, USA.
- School of Medicine, University of Crete, 710 03 Heraklion, Greece.
- General Directorate of Public Health and Social Welfare, Attica Region, 115 21 Athens, Greece.
- Laboratory of Clinical Chemistry, School of Health Sciences, Faculty of Medicine, University of Ioannina, 451 10 Ioannina, Greece.
ORCID-Profile: Shanna Rodriguez Polanco, Christina E Kostara
Zitieren
APA
Kosmas, C. E., Rodriguez Polanco, S., Bousvarou, M. D., Papakonstantinou, E. J., Peña Genao, E., Guzman, E., & Kostara, C. E. (2023). The Triglyceride/High-Density Lipoprotein Cholesterol (TG/HDL-C) Ratio as a Risk Marker for Metabolic Syndrome and Cardiovascular Disease. Diagnostics, 13(5), 929. https://doi.org/10.3390/diagnostics13050929
Vancouver
Kosmas CE, Rodriguez Polanco S, Bousvarou MD, Papakonstantinou EJ, Peña Genao E, Guzman E, et al. The Triglyceride/High-Density Lipoprotein Cholesterol (TG/HDL-C) Ratio as a Risk Marker for Metabolic Syndrome and Cardiovascular Disease. Diagnostics. 2023;13(5):929. doi:10.3390/diagnostics13050929
BibTeX
@article{Kosmas2023,
author = {Kosmas, Constantine E and Rodriguez Polanco, Shanna and Bousvarou, Maria D and Papakonstantinou, Evangelia J and Peña Genao, Edilberto and Guzman, Eliscer and Kostara, Christina E},
title = {The Triglyceride/High-Density Lipoprotein Cholesterol (TG/HDL-C) Ratio as a Risk Marker for Metabolic Syndrome and Cardiovascular Disease},
journal = {Diagnostics},
year = {2023},
volume = {13},
number = {5},
pages = {929},
doi = {10.3390/diagnostics13050929}
}
EUVIMED